Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
2.920
+0.770 (35.81%)
At close: Aug 10, 2026, 4:00 PM EDT
3.070
+0.150 (5.14%)
After-hours: Aug 10, 2026, 4:47 PM EDT

Jin Medical International Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
2388421170--
Market Cap Growth
-77.15%-79.00%147.99%---
Enterprise Value
13.6677.66405.7157.2200
Last Close Price
2.9211.3053.8023.40--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PE Ratio
14.3556.50134.5058.50--
PS Ratio
0.854.2817.928.57--
PB Ratio
0.562.9814.617.08--
P/TBV Ratio
0.783.1015.217.13--
P/FCF Ratio
---56.75--
P/OCF Ratio
-30.46-54.66--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
EV/Sales Ratio
0.393.7517.267.93--
EV/EBITDA Ratio
11.6191.20104.6550.83--
EV/EBIT Ratio
18.25127.70111.4954.83--
EV/FCF Ratio
---52.54--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
0.690.640.400.1700
Debt / EBITDA Ratio
31.8022.212.991.33--
Debt / FCF Ratio
---1.37--
Net Debt / Equity Ratio
-0.30-0.36-0.53-0.52-0.46-0.41
Net Debt / EBITDA Ratio
-14.00-12.59-3.91-4.07-2.83-1.92
Net Debt / FCF Ratio
1.322.8811.21-4.21-4.59-0.99
Asset Turnover
0.350.420.600.740.900.97
Inventory Turnover
4.982.902.742.21-1.91-2.08
Quick Ratio
1.561.492.062.821.961.40
Current Ratio
1.951.862.503.493.312.47
Return on Equity (ROE)
4.64%4.75%13.02%14.68%18.50%21.20%
Return on Assets (ROA)
0.83%1.39%10.93%11.79%9.82%11.26%
Return on Invested Capital (ROIC)
2.21%4.28%34.71%32.44%25.53%25.43%
Return on Capital Employed (ROCE)
1.27%2.09%13.83%14.62%14.56%21.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
6.97%1.77%0.74%1.71%--
FCF Yield
---1.76%--
Buyback Yield / Dilution
--0.05%-7.81%-7.51%0.00%0.00%
Total Shareholder Return
--0.05%-7.81%-7.51%0.00%0.00%
SEC Filings: 10-K · 10-Q